Advertisement

Human Genetics

, Volume 133, Issue 1, pp 111–116 | Cite as

Genetic testing and genetic counseling among medicaid-enrolled children with autism spectrum disorder in 2001 and 2007

  • Lindsay SheaEmail author
  • Craig J. Newschaffer
  • Ming Xie
  • Scott M. Myers
  • David S. Mandell
Original Investigation

Abstract

The rise in the prevalence of autism spectrum disorder (ASD) has resulted in increased efforts to understand the causes of this complex set of disorders that emerge early in childhood. Although research in this area is underway and yielding useful, but complex information about ASD, guidelines for the use of genetic testing and counseling among children with ASD conflict. The purpose of this study was to determine the frequency of use of genetic testing and counseling before the widespread implementation of clinical chromosomal microarray (CMA) to establish a baseline for the use of both services and to investigate potential disparities in the use of both services among children with ASD. We found that about two-thirds of children with ASD received genetic testing or counseling and the use of both services is increasing with time, even in the pre-CMA era. Being female and having a comorbid intellectual disability diagnosis both increased the likelihood of receiving genetic testing and genetic counseling. Initial discrepancies in the use of both services based on race/ethnicity suggest that troubling disparities observed in other services delivered to children with ASD and other mental health disorders persist in genetic testing and counseling as well. These results should incentivize further investigation of the impact of genetic testing and counseling on children with ASD and their families, and should drive efforts to explore and confront disparities in the delivery of these services, particularly with the advancing scientific research on this topic.

Keywords

Autism Spectrum Disorder Autism Spectrum Disorder Genetic Testing Genetic Counseling Intellectual Disability 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Abrahams BS, Geschwind DH (2008) Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 9(5):341–355PubMedCentralPubMedCrossRefGoogle Scholar
  2. Alegria M, Vallas M et al (2010) Racial and ethnic disparities in pediatric mental health. Child Adolesc Psychiatr Clin N Am 19(4):759PubMedCentralPubMedCrossRefGoogle Scholar
  3. American Academy of Pediatrics (2013). Initial medical evaluation of a child diagnosed with an autism spectrum disorders. Autism: caring for children with autism spectrum disorders: a resource toolkit for clinicians B. C. In: Hyman SL, Levy SE (eds). American Academy of Pediatrics, Elk Grove VillageGoogle Scholar
  4. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. Text Revision, Washington DCGoogle Scholar
  5. Aratani Y, Cooper JL (2012) Racial and ethnic disparities in the continuation of community-based children’s mental health services. J Behav Health Serv Res 39(2):116–129PubMedCrossRefGoogle Scholar
  6. Caronna E, Milunsky J et al (2008) Autism spectrum disorders: clinical and research frontiers. Arch Dis Child 93:518–523PubMedCrossRefGoogle Scholar
  7. Chakrabarti S, Fombonne E (2001) Pervasive developmental disorders in preschool children. J Am Med Assoc 285(24):3093–3099CrossRefGoogle Scholar
  8. Constantino JN, Zhang Y et al (2010) Sibling recurrence and the genetic epidemiology of autism. Am J Psychiatry 167(11):1349–1356PubMedCentralPubMedCrossRefGoogle Scholar
  9. Cooper GM, Coe BP et al (2011) A copy number variation morbidity map of developmental delay. Nat Genet 43(9):U838–U844CrossRefGoogle Scholar
  10. Coulter ME, Miller DT et al (2011) Chromosomal microarray testing influences medical management. Genet Med 13(9):770–776PubMedCrossRefGoogle Scholar
  11. Edwards A, Elwyn G (2001) Understanding risk and lessons for clinical risk communication about treatment preferences. Qual Health Care 10:i9–i13PubMedCentralPubMedCrossRefGoogle Scholar
  12. El-Fishawy P, State M (2010) The genetics of autism: key issues, recent findings, and clinical implications. Psychiatr Clin North Am 33(1):83–105PubMedCentralPubMedCrossRefGoogle Scholar
  13. Ellison JW, Ravnan JB et al (2012) Clinical utility of chromosomal microarray analysis. Pediatrics 130(5):E1085–E1095PubMedCrossRefGoogle Scholar
  14. Filipek PA, Accardo PJ et al (2000) Practice parameter: screening and diagnosis of autism—report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 55(4):468–479PubMedCrossRefGoogle Scholar
  15. Folstein S, Rutter M (1977) Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry 18:297–321PubMedCrossRefGoogle Scholar
  16. Freitag CM, Staal W et al (2010) Genetics of autistic disorders: review and clinical implications. Eur J Child Adolesc Psychiatry 19(3):169–178CrossRefGoogle Scholar
  17. Girirajan S, Rosenfeld JA et al (2010) A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet 42(3):203–209PubMedCentralPubMedCrossRefGoogle Scholar
  18. Gupta AR (2007) Recent advances in the genetics of autism. Biol Psychiatry 61(4):429–437PubMedCrossRefGoogle Scholar
  19. Hilton CL, Fitzgerald RT et al (2010) Brief report: under-representation of African Americans in autism genetic research: a rationale for inclusion of subjects representing diverse family structures. J Autism Dev Disord 40(5):633–639PubMedCentralPubMedCrossRefGoogle Scholar
  20. International Molecular Genetic Study of Autism Consortium (IMGSAC) (2001) A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet 69(3):570–581CrossRefGoogle Scholar
  21. Johnson CP, Myers SM et al (2007) Identification and evaluation of children with autism spectrum disorders. Pediatrics 120(5):1183–1215PubMedCrossRefGoogle Scholar
  22. Kaminsky EB, Kaul V et al (2011) An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet Med 13(9):777–784PubMedCentralPubMedCrossRefGoogle Scholar
  23. Leblond CS, Heinrich J et al (2012) Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet 8(2):e1002521PubMedCentralPubMedCrossRefGoogle Scholar
  24. Mandell DS, Novak M (2005) The role of culture in families’ treatment decisions for children with autism spectrum disorders. Ment Retard Dev Disabil Res Rev 11(2):110–115PubMedCrossRefGoogle Scholar
  25. Mandell D, Listerud J et al (2002) Race differences in the age at diagnosis among medicaid-eligible children with autism. J Am Acad Child Adolesc Psychiatry 41(12):1447–1453PubMedCrossRefGoogle Scholar
  26. Mandell DS, Ittenbach RF et al (2007) Disparities in diagnoses received prior to a diagnosis of autism spectrum disorder. J Autism Dev Disord 37(9):1795–1802PubMedCentralPubMedCrossRefGoogle Scholar
  27. Mandell DS, Wiggins LD et al (2009) Racial/ethnic disparities in the identification of children With autism spectrum disorders. Am J Public Health 99(3):493–498PubMedCrossRefGoogle Scholar
  28. Mandell D, Morales K et al (2010a) County-level variation in the prevalence of medicaid-enrolled children with autism spectrum disorders. J Autism Dev Disord 40(10):1241–1246PubMedCentralPubMedCrossRefGoogle Scholar
  29. Mandell DS, Morales KH et al (2010b) Age of diagnosis among medicaid-enrolled children with autism, 2001–2004. Psychiatr Serv 61(8):822–829PubMedCentralPubMedCrossRefGoogle Scholar
  30. Manning M, Hudgins L et al (2010) Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 12(11):742–745PubMedCentralPubMedCrossRefGoogle Scholar
  31. Maulik PK, Mascarenhas MN et al (2011) Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil 32(2):419–436PubMedCrossRefGoogle Scholar
  32. McGrew SG, Peters BR et al (2012) Diagnostic yield of chromosomal microarray analysis in an autism primary care practice: which guidelines to implement? J Autism Dev Disord 42(8):1582–1591PubMedCrossRefGoogle Scholar
  33. Mendelsohn NJ, Schaefer GB (2008) Genetic evaluation of autism. Semin Pediatr Neurol 15(1):27–31PubMedCrossRefGoogle Scholar
  34. Miller D (2010) Genetic testing for autism: recent advances and clinical implications. Expert Rev Mol Diagn 10(7):837–840PubMedCrossRefGoogle Scholar
  35. Miller DT, Adam MP et al (2010a) Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86(5):749–764PubMedCentralPubMedCrossRefGoogle Scholar
  36. Miller FA, Hayeems RZ et al (2010b) What is a meaningful result? Disclosing the results of genomic research in autism to research participants. Eur J Hum Genet 18(8):867–871PubMedCrossRefGoogle Scholar
  37. Muhle R, Trentacoste SV et al (2004) The genetics of autism. Pediatrics 113(5):E472–E486PubMedCrossRefGoogle Scholar
  38. Ozonoff S, Young GS et al (2011) Recurrence risk for autism spectrum disorders: a baby siblings research consortium study. Pediatrics 128(3):E488–E495PubMedGoogle Scholar
  39. Regier DA, Friedman JM et al (2010) Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability. Am J Hum Genet 86(5):765–772PubMedCentralPubMedCrossRefGoogle Scholar
  40. Roesser J (2011) Diagnostic yield of genetic testing in children diagnosed with autism spectrum disorders at a regional referral center. Clin Pediatr 50(9):834–843CrossRefGoogle Scholar
  41. Saam J, Gudgeon J et al (2008) How physicians use array comparative genomic hybridization results to guide patient management in children with developmental delay. Genet Med 10(3):181–186PubMedCrossRefGoogle Scholar
  42. Schaaf CP, Sabo A et al (2011) Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. Hum Mol Genet 20(17):3366–3375PubMedCrossRefGoogle Scholar
  43. Schaefer GB, Mendelsohn NJ (2008a) Clinical genetics evaluation in identifying the etiology of autism spectrum disorders. Genet Med 10(4):301–305PubMedCentralPubMedCrossRefGoogle Scholar
  44. Schaefer GB, Mendelsohn NJ (2008b) Genetics evaluation for the etiologic diagnosis of autism spectrum disorders. Genet Med 10(1):4–12PubMedCrossRefGoogle Scholar
  45. Semansky RM, Xie M et al (2011) Medicaid’s increasing role in treating youths with autism spectrum disorders. Psychiatr Serv 62(6):588PubMedCrossRefGoogle Scholar
  46. Shen YP, Dies KA et al (2010) Clinical genetic testing for patients with autism spectrum disorders. Pediatrics 125(4):E727–E735PubMedCrossRefGoogle Scholar
  47. Singer E, Antonucci T et al (2004) Racial and ethnic variation in knowledge and attitudes about genetic testing. Genet Test 8(1):31–43PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Lindsay Shea
    • 1
    Email author
  • Craig J. Newschaffer
    • 1
  • Ming Xie
    • 2
  • Scott M. Myers
    • 3
  • David S. Mandell
    • 2
    • 4
  1. 1.A.J. Drexel Autism InstituteDrexel UniversityPhiladelphiaUSA
  2. 2.Center for Mental Health Policy and Services ResearchUniversity of PennsylvaniaPhiladelphiaUSA
  3. 3.Geisinger Health SystemDanvilleUSA
  4. 4.Center for Autism ResearchChildren’s Hospital of PhiladelphiaPhiladelphiaUSA

Personalised recommendations